Literature DB >> 2809154

Innervation of intrahepatic bile ducts and peribiliary glands in normal human livers, extrahepatic biliary obstruction and hepatolithiasis. An immunohistochemical study.

T Terada1, Y Nakanuma.   

Abstract

Innervation of the intrahepatic biliary tree was examined in human normal livers, extrahepatic biliary obstruction and hepatolithiasis. Nerve fibers were immunohistochemically identified on formalin-fixed and paraffin-embedded sections by antibodies to S-100 protein (S-100) and neuron specific enolase (NSE). S-100 and NSE-immunoreactive nerve fibers were present in the walls of intrahepatic large, medium-sized and septal bile ducts as well as in peribiliary glands. Some nerve fibers were in close contact with epithelia of bile ducts and peribiliary glands. Serial section observations showed that the nerve fibers arising from nerve bundles approached, and came to lie in close contact with epithelia of the bile ducts and peribiliary glands. Nerve fibers were sparse around the interlobular bile ducts and bile ductules. These immunoreactive nerve fibers of the intrahepatic biliary tree were rather sparse in normal livers, intermediate in extrahepatic biliary obstruction and dense in hepatolithiasis. These findings suggest that intrahepatic bile ducts and peribiliary glands are innervated and biliary functions are regulated in part by these nerve fibers. Increased nerve fibers may have altered effects on biliary functions in hepatolithiasis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2809154     DOI: 10.1016/0168-8278(89)90044-5

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  17 in total

1.  An anterograde tracing study of the vagal innervation of rat liver, portal vein and biliary system.

Authors:  H R Berthoud; M Kressel; W L Neuhuber
Journal:  Anat Embryol (Berl)       Date:  1992-10

2.  Primary intrahepatic cholesterol stones. Report of one case and treatment with ursodeoxycholic acid.

Authors:  Y Schillio; G Amouyal; B Gayet; M Dumont; C Degott; S Erlinger
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

3.  Interactions between epithelial and mesenchymal cells in intrahepatic peribiliary glands in normal and hepatolithiatic livers.

Authors:  N Kono; T Terada; Y Nakanuma
Journal:  Gastroenterol Jpn       Date:  1991-04

Review 4.  Functional anatomy of normal bile ducts.

Authors:  Mario Strazzabosco; Luca Fabris
Journal:  Anat Rec (Hoboken)       Date:  2008-06       Impact factor: 2.064

Review 5.  Pathobiology of biliary epithelia.

Authors:  Angela C Cheung; Maria J Lorenzo Pisarello; Nicholas F LaRusso
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-07-15       Impact factor: 5.187

6.  Identification of intramural epithelial networks linked to peribiliary glands that express progenitor cell markers and proliferate after injury in mice.

Authors:  Frank DiPaola; Pranavkumar Shivakumar; Janet Pfister; Stephanie Walters; Gregg Sabla; Jorge A Bezerra
Journal:  Hepatology       Date:  2013-08-06       Impact factor: 17.425

7.  Spread of hilar cholangiocarcinomas via peribiliary gland network: a hither-to-unrecognized route of periductal infiltration.

Authors:  Hirohide Sato; Yasuni Nakanuma; Kazuto Kozaka; Yasunori Sato; Hiroko Ikeda
Journal:  Int J Clin Exp Pathol       Date:  2013-01-15

Review 8.  Significance of controlling chronic proliferative cholangitis in the treatment of hepatolithiasis.

Authors:  Fu Yu Li; Nan Sheng Cheng; Hui Mao; Li Sheng Jiang; Jing Qiu Cheng; Quan Sheng Li; Sanjay Munireddy
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

9.  Ontogeny of human intrahepatic innervation.

Authors:  Dina G Tiniakos; Joseph Mathew; Christos Kittas; Alastair D Burt
Journal:  Virchows Arch       Date:  2008-01-15       Impact factor: 4.064

10.  Treatment of chronic proliferative cholangitis with c-myc shRNA.

Authors:  Fu-Yu Li; Nan-Sheng Cheng; Jing-Qiu Cheng; Hui Mao; Li-Sheng Jiang; Ning Li; Sheng He
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.